Catherine Moukheibir - 15 Mar 2023 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Mar 2023
Net transactions value
$0
Form type
4
Filing time
17 Mar 2023, 16:05:12 UTC
Previous filing
03 Jun 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1,677 +1.7% $0.000000 101,027 15 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2023.